Takafumi Koyoma

37PUBLICATIONS
200CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Sep 22, 2026
Comprehensive Genomic Profiling Beyond Driver Testing in Non-Squamous Non-Small Cell Lung Cancer With Known Drivers.

|Sep 08, 2026
Autologous Glypican-3-Targeted, Armored CAR T Cells in Patients with Advanced Solid Tumors: A Phase 1 Dose-Escalation Study of TAK-102.

|Sep 04, 2026
A Phase I Study of PF-07062119, an Anti-GUCY2C/Anti-CD3 Bispecific Fc Antibody, in Patients with Advanced Gastrointestinal Cancers.

|May 18, 2026
Phase I Study of Rogocekib in Patients with Advanced, Relapsed, or Refractory Malignant Solid Tumors.

|Mar 13, 2026
Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human study.

Yonina R Murciano-Goroff, Antoine Hollebecque, Rebecca S Heist

|Jan 15, 2026
Comprehensive Genomic Profiling of Advanced Anal Adenocarcinoma in Japan.

Nozomu Ogura, Hidekazu Hirano, Kouya Shiraishi

Pageof 7

Frequent Collaborators

21 joint publications

Noboru Yamamoto

12 joint publications

Kan Yonemori

11 joint publications

Shunsuke Kondo

9 joint publications

Jun Sato